Navigation Links
Kosan in Medical News

Sunesis Pharmaceuticals Appoints Helen S. Kim to Board of Directors

...s currently a Director and Chief Executive Officer of privately held TRF Pharma, Inc. Previously, she was the Chief Executive Officer and President of kosan Biosciences Incorporated where she restructured and repositioned the company prior to successfully selling the company to Bristol-Myers Squibb in 2008...

New Report Just Published: World Multiple Myeloma Therapeutics Market Report

...armaceuticals, Inc., Bristol-Myers Squibb Company, kosan Biosciences, Inc., Celgene Corporation, F. Hoffman...ual Agreement II-47 Bristol-Myers to Take Over kosan Biosciences II-47 Bristol and PDL BioPharma En...5 Bristol-Myers Squibb Company (USA) II-55 kosan Biosciences, Inc. (USA) II-55 Celgene Corporat...

Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma

... kosan Leads Industry with Most Advanced Hsp90 Inhibitor ... HAYWARD, Calif., Jan. 3 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an... single prior course of treatment (first-relapse). kosan has completed both a Special Protocol Assessment w...

Kosan Announces November 8, 2007 Conference Call and Webcast of Third Quarter 2007 Financial Results

... HAYWARD, Calif., Nov. 2 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) will ann...n dial 617.801.6888, access code: 98027185. About kosan kosan Biosciences is a biotechnology company advancing t...
Kosan in Medical Technology

Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial

... HAYWARD, Calif., June 3 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...emedications and ease of pharmacist preparation. kosan anticipates conducting additional studies with tan...s trastuzumab will continue on study per protocol. kosan does not plan to enroll additional patients in thi...

Kosan Announces Data Presentations at ASCO 2008 Annual Meeting

... HAYWARD, Calif., May 14 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...of the University of Pennsylvania. About Kosan kosan Biosciences is a biotechnology company advancing t... in a Phase 1 trial. For additional information on kosan Biosciences, please visit the company's website at...

Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR

...AYWARD, Calif., April 16 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) presente...all of the leukemia models tested. About Kosan kosan Biosciences is a biotechnology company advancing t... in a Phase 1 trial. For additional information on kosan Biosciences, please visit the company's website at...

Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer

...AYWARD, Calif., April 14 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...disease in many additional tumors. About Kosan kosan Biosciences is a biotechnology company advancing t... in a Phase 1 trial. For additional information on kosan Biosciences, please visit the company's website at...

Kosan Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer

...HAYWARD, Calif., Jan. 15 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...t cancer represents a major market opportunity for kosan that we intend to pursue," said Robert G. Johnson,...hree weeks out of four weeks in repeated cycles. kosan is also testing alvespimycin delivered orally in a...

Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash

... HAYWARD, Calif., Dec. 8 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) presente...d to be progression-free survival. About Kosan kosan Biosciences is a biotechnology company advancing t...heat shock protein 90) inhibitors and epothilones. kosan is leveraging its proprietary discovery platform t...

Kosan Presents Phase 1 Data Showing Antitumor Activity and Safety Profile of Epothilone KOS-1584 at AACR/NCI/EORTC Meeting

...HAYWARD, Calif., Oct. 23 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) presente...pending on data from expanded dose cohorts. About kosan kosan Biosciences is a biotechnology company advancing t...

Kosan's Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial

...AYWARD, Calif., Sept. 10 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) presente...with reduced doses (one patient remains on study). kosan plans to continue to enroll patients at the 80 mg/...tion. Expanded Phase 1 Trial Includes Paclitaxel kosan has expanded the Phase 1 trial to add weekly dosin...

Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma

...HAYWARD, Calif., Sept. 6 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...e FDA's Special Protocol Assessment (SPA) process, kosan and the FDA have reached agreement on overall prot...-agent bortezomib. The Special Protocol Assessment kosan has completed applies to the TIME-1 trial. TIME-2,...

Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma

... HAYWARD, Calif., Aug. 2 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...ed primarily by the patient's level of M protein. kosan anticipates that the pivotal TIME-1 trial will beg...ion of cytotoxic proteins, leading to cell death. kosan reported data from a Phase 1b trial of tanespimyci...

More>>

Kosan in Biological Technology

Proteolix Announces New Appointment in Finance and Expands Clinical and Regulatory Leadership Team

...tory bodies outside the United States. Dr. Kraus joins Proteolix from kosan Biosciences (acquired by Bristol-Myers Squibb in 2008), where he served as ...velopment strategy of Kosan's oncology product portfolio. Prior to joining kosan in 2006, he was Group Director, Global Regulatory Strategy, Oncology with B...

Kosan Appoints Pamela S. Cohen, M.D., as Chief Medical Officer

... HAYWARD, Calif., May 20 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...ologist, most notably at Novartis. Dr. Cohen joins kosan from GE Healthcare Medical Diagnostics where she s... use in oncology drug development. About Kosan kosan Biosciences is a biotechnology company advancing t...

Kosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable Conference

... HAYWARD, Calif., May 6 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) announce...s will be available for two weeks. About Kosan kosan Biosciences is a biotechnology company advancing t... in a Phase 1 trial. For additional information on kosan Biosciences, please visit the company's website at...

Kosan Announces May 1, 2008 Conference Call and Webcast of First Quarter 2008 Financial Results

...AYWARD, Calif., April 25 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) will ann...7-801-6888, access code: 17626068. About Kosan kosan Biosciences is a biotechnology company advancing t... in a Phase 1 trial. For additional information on kosan Biosciences, please visit the company's website at...

Kosan Presents Preclinical Data on Novel Third-Generation Hsp90 Inhibitors at AACR

...AYWARD, Calif., April 16 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) presente...ntial as a novel anticancer agent. About Kosan kosan Biosciences is a biotechnology company advancing t... in a Phase 1 trial. For additional information on kosan Biosciences, please visit the company's website at...

Kosan Restructures Workforce to Focus Resources on Lead Clinical Programs

...AYWARD, Calif., March 18 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...high-value, near-term commercial opportunities." kosan anticipates incurring restructuring charges of app...40-$50 million to $37-$47 million. About Kosan kosan Biosciences is a biotechnology company advancing t...

Kosan's Board of Directors Appoints Helen S. Kim as Chief Executive Officer

...AYWARD, Calif., March 18 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...e Officer, effectively immediately. Ms. Kim joined kosan in January 2008 as Senior Vice President and Chief...erience, demonstrated leadership and commitment to kosan to ensure that our company can operate at the high...

Kosan Biosciences to Present at the Cowen and Company 28th Annual Health Care Conference

...AYWARD, Calif., March 14 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) announce...n will be available for two weeks. About Kosan kosan Biosciences is a biotechnology company advancing t...ux disease (GERD). For additional information on kosan Biosciences, please visit the company's website at...

Kosan Biosciences to Present at the Susquehanna Second Annual SIGnificant Options in Healthcare Conference

...HAYWARD, Calif., Feb. 29 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) announce...s will be available for two weeks. About Kosan kosan Biosciences is a biotechnology company advancing t...ux disease (GERD). For additional information on kosan Biosciences, please visit the company's website at...

Kosan Announces Senior Management Changes and Clinical Portfolio Priorities

...HAYWARD, Calif., Feb. 28 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...san's Board of Directors. Helen S. Kim, who joined kosan in January 2008 as Senior Vice President and Chief... President of Kosan. "Under Robert's leadership, kosan made the successful transition from a research-ori...
Other Tags
(Date:11/27/2014)... MN (PRWEB) November 27, 2014 ... of office ergonomics equipment , has announced that ... with Commercial Office Environments. The partnership will put ... office furnishings location. , In addition to having ... new dealer partnership promotes HealthPostures' products with the ...
(Date:11/27/2014)... Allowing children to help with chores while ... give children responsibility, ownership, boosts self-esteem, and above all, helps ... the real question is, how do you encourage your children ... a study published by Child Development Journal, there is. The ... on a child’s willingness to lend a hand. , ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 "The uglier, the ... month of December is full of laughter as we enjoy ... won by making a sweater from scratch. " It was ... tree, and if that weren't ridiculous enough, the Christmas balls ... , For those interested in participating this year, it's ...
(Date:11/27/2014)... Ethane Web Technologies, which is an ... reputation management service. , The company has designed ... world of internet marketing and algorithms of major search ... Web Technologies does not work with the same strategy ... to reach a conclusion what will work for the ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Ethane Web Technologies, ... it will provide a 10% Christmas discount on PPC service. ... December. The discount offer will begin on 1 December 2014 ... , About this offer, a PPC professional working at Ethane ... especially for small businesses, as this big discount would make ...
Breaking Medicine News(10 mins):Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 3Health News:Ethane Web Technologies Announces Online Reputation Management Service 2Health News:Ethane Web Technologies Announces 10% Christmas Discount on PPC Service 2
(Date:11/3/2014)... 2014  NeuroSigma ® , Inc. (NeuroSigma), a ... focused on commercialization of its non-invasive ... of neurological and neuropsychiatric disorders, announced today that ... a Notice of Allowance for Mexican Patent Application ... NeuroSigma and the Regents of the University of ...
(Date:11/2/2014)... , James Dacey explores the ways in which physicists ... innovations from the lab into the commercial market. , ... companies as they move from prototype to product is ... physics-based inventions are usually far from market-ready when initially ... lot more complicated than had been originally thought. , ...
(Date:11/2/2014)... put a flashlight up to our palms to see ... St. Louis engineers are using a similar idea to ... of cancerous tissues and to develop potential treatments. ... Professor of Biomedical Engineering at the School of Engineering ... that allows researchers to better focus light in tissue, ...
Breaking Biology News(10 mins):NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3The 'valley of death' facing physics start-ups 2Improving imaging of cancerous tissues by reversing time 2
Other Contents